Actively Recruiting
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Led by Sanofi · Updated on 2025-06-29
200
Participants Needed
1
Research Sites
109 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three months of treatment with standard of care therapy. The study is expected to last two years. Enrollment is expected to continue for one year. Depending on when the participant is enrolled, a participant can be followed for between one and two years, through the end of study, approximately two years after the study starts.
CONDITIONS
Official Title
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Neurologist-confirmed diagnosis of CIDP with no reversal of diagnosis before enrollment
- Active use of at least one CIDP treatment for three months or longer with no discontinuation before enrollment, including immunoglobulin, corticosteroids (except low-dose prednisone monotherapy at 10mg or less per day), plasma exchange, efgartigimod alfa, azathioprine, mycophenolate mofetil, cyclosporine, rituximab, or methotrexate
- Signed informed consent
- Residual impairment, disability, or neurological deficits at enrollment indicated by a raw I-RODS score of 44 or below
You will not qualify if you...
- Participation in any interventional clinical trial with an investigational drug at enrollment
- Hyperreflexia recorded during neurological exam within the year before enrollment after CIDP diagnosis
- Under 18 years old at enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Investigational Site
Swiftwater, Pennsylvania, United States, 18370-0187
Actively Recruiting
Research Team
T
Trial Transparency email recommended (Toll free for US & Canada)
CONTACT
P
PicnicHealth For potential study participants
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here